The FDA has issued guidance stating it will not prioritize enforcement against certain unauthorized e-cigarette and oral nicotine pouch products.

The Tobacco Control Act requires that new tobacco products cannot be legally marketed without pre-market authorization from the FDA.

Harry Nelson predicts that states will likely increase enforcement on e-cigarettes to fill the void left by the federal government's relaxed stance.

It has been 26 years since the last clinical review of mifepristone, and there is no record of serious adverse events associated with the drug.